FDA
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
-
-
-
-
-
-
-
This biotech stock is on TD Cowen's best smidcap ideas list
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Changes to Board of Directors
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $130 at RBC Capital
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
329,871 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

